Celldex Therapeutics, Inc. (CLDX) Net margin 2021–2025
Celldex Therapeutics, Inc. (CLDX) net profit margin by fiscal year — reported net income divided by reported revenue.
-16748.0%FY2025 · since FY2021: -1516.0% → -16748.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16748.0% | -14499.3 pp |
| FY2024 | -2248.8% | -194.0 pp |
| FY2023 | -2054.8% | +2710.8 pp |
| FY2022 | -4765.6% | -3249.6 pp |
| FY2021 | -1516.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice